AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Grams, F Brandstetter, H D'Alo, S Geppert, D Krell, HW Leinert, H Livi, V Menta, E Oliva, A Zimmermann, G
Citation: F. Grams et al., Pyrimidine-2,4,6-triones: A new effective and selective class of matrix metalloproteinase inhibitors, BIOL CHEM, 382(8), 2001, pp. 1277-1285

Authors: Brandstetter, H Grams, F Glitz, D Lang, A Haber, R Bode, W Krell, HW Engh, RA
Citation: H. Brandstetter et al., The 1.8-angstrom crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition (vol 276, 17405, 2001), J BIOL CHEM, 276(33), 2001, pp. 31474-31474

Authors: Brandstetter, H Grams, F Glitz, D Lang, A Huber, R Bode, W Krell, HW Engh, RA
Citation: H. Brandstetter et al., The 1.8-angstrom crystal structure of a matrix metallaproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition, J BIOL CHEM, 276(20), 2001, pp. 17405-17412

Authors: Pinna, GA Curzu, MM Murineddu, G Chelucci, G Cignarella, G Menta, E Krell, HW Rastelli, G Ferrari, AM
Citation: Ga. Pinna et al., Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors, ARCH PHARM, 333(2-3), 2000, pp. 37-47

Authors: Maquoi, E Frankenne, F Noel, A Krell, HW Grams, F Foidart, JM
Citation: E. Maquoi et al., Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells, EXP CELL RE, 261(2), 2000, pp. 348-359

Authors: Grams, F Brandstetter, H Engh, RA Glitz, D Krell, HW Livi, V Menta, E Moroder, L Constanze, J Muller, D von Roedern, EG Zimmermann, G
Citation: F. Grams et al., Research on MMP inhibitors with unusual scaffolds, CANC DRUG, 2000, pp. 223-243

Authors: Brakebusch, C Wennerberg, K Krell, HW Weidle, UH Sallmyr, A Johansson, S Fassler, R
Citation: C. Brakebusch et al., beta 1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts, ONCOGENE, 18(26), 1999, pp. 3852-3861

Authors: Della Porta, P Soeltl, R Krell, HW Collins, K O'Donoghue, M Schmitt, M Kruger, A
Citation: P. Della Porta et al., Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo, ANTICANC R, 19(5B), 1999, pp. 3809-3816
Risultati: 1-8 |